Search results

Selected filters:

Litigation
Analysis

Article type

Topic

Sector

Regions

Year

1,508 results found for your search

Sort options
19 February 2019

New Acacia chief IP officer charts a different course for the once mighty NPE

Supported by a healthy balance sheet, Marc Booth says the firm plans on a higher volume of smaller deals with three new areas identified for future growth

19 February 2019

With Oppo deal, Ericsson gets crucial SEP validation in China

Securing a FRAND licence with the world’s fifth largest handset maker could be a shot in the arm for the Swedish company, which has struggled to get royalties out of Chinese firms like Xiaomi and TCL

15 February 2019

AbbVie’s Humira strategy to be scrutinised in first evergreening unclean hands challenge

In a Delaware case Boehringer Ingelheim accuses the Illinois company of improper conduct in deliberately constructing a patent thicket to protect against generic versions of its blockbuster drug.

14 February 2019

As 101 debate continues, Iancu offers clear message to Federal Circuit

With new guidelines set to reshape patent examination, the USPTO head makes the case for revisiting subject matter precedent

14 February 2019

World’s most valuable startup buys patents again

The company behind Tik Tok bought out much of a struggling smartphone maker’s patent portfolio in January. USPTO assignments from last week show what assets Beijing-based ByteDance came away with

11 February 2019

RPX strikes deal to acquire remaining patent portfolio of Creative subsidiary

The settlement deal ends litigation by the Singapore company’s ZiiLabs unit against Nvidia, and will net shareholders around $17.5 million

11 February 2019

Apple’s courtroom strategy shows team monetising former portfolio of Blackberry patents faces biggest licensing challenge

The iPhone maker moves for declaratory judgment claiming non infringement of grants relating to charging technology

08 February 2019

The US’s first all biosimilar patent suit shows new pharma IP landscape is emerging

Coherus launched Delaware action against Amgen in what is likely to become an increasingly familiar life sciences litigation scenario.

08 February 2019

US patent system jumps to second in the world, though the biopharma sector may not agree

PTAB reforms help fuel a miraculous rise up the latest International IP Index, but a recent Federal Circuit decision on eligibility highlights the serious challenges that remain - especially for life sciences companies

07 February 2019

An entire “industry revolt” hinges on judge’s decision in FTC v Qualcomm

If the Commission and Apple are successful in rewriting the rules for chipmaker's licensing arm beware of unintended consequences that reduce choice and harm consumers, expert analyst states

07 February 2019

An insider look at the IP Asia Elite

The newest members of IAM's IP Asia Elite give us the inside scoop on what makes a great IP function tick  

05 February 2019

TiVo might be about to split at a time when its licensing business has significant concerns

Latest report suggests that result of a strategic review will see the company's product and IP arms separate, but current courtroom tussle with Comcast means the timing is not great

04 February 2019

As 5th birthday nears LOTNet aims to prove you can monetise patents and be a member at the same time

After Microsoft's headline grabbing decision to sign-up to the network last year, LOT CEO “absolutely expects IBM to join” once its Red Hat acquisition is finalised

01 February 2019

Still no sign of a patent war as the world’s largest automakers see US litigation slump

Ford faces new confrontation over alleged infringement of MIT-owned IP, but number of suits against car giant well down from 2012-2014 peak

31 January 2019

Excalibur IP accuses Spotify of infringing former Yahoo! patents

Delaware lawsuit is first move to litigate assets since former RPX dealmaker took control of portfolio